If you enjoy this content, please share it with a colleague
Philips
RELATED CONTENT
Philips released the Philips Clinical Review Display, a new solution for the fast-growing medical facilities market in Hong Kong. With aging population a worldwide phenomenon and computerized imaging systems for health diagnostics rapidly developing, the demand for quality clinical displays is increasing.
Royal Philips and Accenture announced the creation of a proof-of-concept (POC) demonstration that uses a Google Glass head-mounted display for researching ways to improve the effectiveness and efficiency of performing surgical procedures. The demonstration connects Google Glass to Philips IntelliVue Solutions and proves the concept of seamless transfer of patient vital signs into Google Glass, potentially providing physicians with hands-free access to critical clinical information.
Philips Speech Processing Solutions announced it will partner with ZyDoc, a medical transcription, speech recognition and natural language processing (NLP) technologies integrator, to continue to provide advances in voice productivity solutions.
The addition of magnetic resonance (MR) imaging and spectroscopy to positron emission tomography (PET) is more expensive and more technically challenging compared with PET/computed tomography (CT). PET/CT is successful because the inclusion of CT has major advantages: accurate lesion localization, the identification of non-PET avid lesions and effective attenuation correction in a rapid, efficient combined examination. The addition of CT is particularly valuable for lungs and liver, where fluorodeoxyglucose (FDG) PET is limited by spatial resolution and relatively low target-to-background differential biodistribution. Presumably, PET/MR may disclose unique important diagnostic and prognostic information in selected patient groups.
With concerns about radiation dose and reducing unnecessary imaging scans, advances in computed tomography (CT) systems have brought about technologies such as iterative reconstruction software, intraoperative capabilities and dose-tracking software. In addition, recent studies on the use of CT on select patient populations and the modality’s benefits in detecting certain cancers are showing that the risks of CT imaging can go both ways. While CT exams can add to a patient’s lifetime exposure to ionizing radiation, they can also be more beneficial in cases where magnetic resonance imaging (MRI) or ultrasound might not be able to detect early-stage cancers. Some of these trends in utilization indicate that appropriate low-dose CT imaging will be key across patient populations.
The use of 3-D echo can help improve the accuracy and reproducibility of cardiac quantification. The technology has the advantage of removing the inter-operator variability by imaging whole volume datasets of the heart, so specific images or organ views can be extracted and reconstructed in any position, similar to CT or MRI datasets. Also, because a volumetric dataset is captured, exam times can be shortened, instead of spending time trying to get just the right angle for a 2-D slice view. Cardiac quantification can also be improved by measuring the entire heart or ventricle, rather than just slices of it. New software also automates this quantification.
Researchers from University Hospitals Case Medical Center have published findings that a new form of imaging — magnetic resonance imaging/ positron emission tomography (PET/MRI) — is promising for several types of cancer.
Philips Healthcare launched the Epiq ultrasound system, a first-of-its-kind ultrasound architecture that offers a new approach to creating ultrasound images. Making its debut at the European Society of Cardiology (ESC) 2013 Congress in Amsterdam, Epiq features a new imaging technology called nSIGHT that, when combined with Philips' new Anatomical Intelligence technology, delivers faster speed and improved image clarity. It has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Today’s remote viewing systems will stimulate changes and challenges in healthcare in a manner similar to what online banking has done for the financial industry. The areas of improvement include safe, secure, remote access from any browser, or ultimately any mobile device. This is the reality of today, and it comes without the need for special applications or image and associated data downloads from virtually any source.
The variety of radiation therapy options continues to grow with the development of treatment planning software, imaging systems for guidance, linear accelerators and more. The external-beam radiation therapy (EBRT) market includes many different types of treatment, from traditional whole-body irradiation (WBI) to conformal radiation therapy (3-D CRT) and intensity-modulated radiation therapy (IMRT). Despite a major decline in 2009, the U.S. radiation therapy market is bouncing back, according to a study published in July by IMV Medical Information Division.[1] Improvements in technologies are helping to drive activity as clinics and hospitals implement advanced techniques to more accurately target and treat cancers.